FDA Inspection 938894 — Carter BloodCare
The FDA completed an inspection of Carter BloodCare on July 10, 2015 in Plano, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 10, 2015
- Fiscal Year
- 2015
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Plano, TX (United States)